International Niemann–Pick Disease Alliance

Menu

Azafaros granted important regulatory designations and clearance by European authorities for global Phase 3 studies, to be initiated in 2025

  • 09.01.25
  • Filed under: Trial Updates
press release CTA and ODT

Join the Registry

Calling all patients and carers! We've created a global registry of all NPD patients - if you're not enrolled yet, join us now...

The Impact of NPC

The global community tell their stories...